bibliographic resource 1230183 [br/1230183]
https://w3id.org/oc/corpus/br/1230183

is a
title
  • A Randomized, Double-Blind Phase 2 Clinical Trial of Blosozumab, a Sclerostin Antibody, in Postmenopausal Women with Low Bone Mineral Density
subtitle
  • PHASE-2 RCT OF BLOSOZUMAB IN POSTMENOPAUSAL WOMEN WITH LOW BMD
publication date
  • 2015-01-01
contributor
format
identifier
part of